NAV
$38.89
AUM
$2.3B
Expense Ratio
-
Dividend Yield
0.00%
Beta
1.07
Currency
USD
| YTD | 1M | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|
| +11.64% | +3.41% | +15.13% | +11.58% | +22.43% | - |
| # | Symbol | Name | Weight |
|---|---|---|---|
| 1 | LRCX | Lam Research Corp | 5.11% |
| 2 | ONTO | Onto Innovation Inc | 3.82% |
| 3 | SCCO | Southern Copper Corp | 3.30% |
| 4 | KLAC | KLA Corp | 3.06% |
| 5 | UTHR | United Therapeutics Corp | 2.29% |
| 6 | MPWR | Monolithic Power Systems Inc | 2.22% |
| 7 | JAZZ | Jazz Pharmaceuticals PLC | 2.16% |
| 8 | NEM | Newmont Corp | 2.02% |
| 9 | ADI | Analog Devices Inc | 2.01% |
| 10 | CGNX | Cognex Corp | 1.61% |
The index uses a rules-based methodology that seeks to provide exposure to large-capitalization U.S. companies with above average free cash flow margins. Under normal circumstances, the fund will seek to invest at least 80% of its net assets, plus the amount of any borrowings for investment purposes, in securities of large-capitalization companies (“large cap”) that are principally traded in the United States.
Inception Date: 2022-12-21